Developer docs
API playgroundTry for free, no card

Search company profiles

HeartcoR Solutions

Full company profile

uuid0005ohi

Namestring
HeartcoR Solutions
Legal namestring
HeartcoR Solutions
Company typeenum
Private
Founded yearint
2015
Descriptiontext

HeartcoR Solutions is a US-based cardiac safety core lab founded in 2015 by Larry Lawson (formerly of eCardio/Preventice Solutions) and headquartered in Schaumburg, Illinois. The company delivers expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to pharmaceutical, medical device, and contract research organization (CRO) customers for global regulatory filings and post-market surveillance studies. It is positioned as the top choice for four of the largest global healthcare companies and also serves startups seeking initial market approval.

The core platform supports four ECG collection modes — Event (60-second recordings), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead — and is paired with a growing remote patient monitoring device portfolio including the Wellysis S-Patch EXL (under exclusive partnership), TempTraq, PCA 500, AliveCor, Vivalink Holter Patch, and Mortara 12-lead. HeartcoR sources, deploys, and integrates these devices at global study sites, patient homes, and decentralized healthcare settings across four continents, completing more than 50,000 tracings annually. A May 2026 strategic partnership with Image Analysis Group (IAG) extends the offering into integrated cardiac safety and multimodality imaging core lab services via IAG's DYNAMIKA platform, addressing sponsor demand for unified vendor relationships in regulatory submissions.

HeartcoR generates revenue through professional services tied to clinical trial cardiac safety monitoring (ECG core lab services), sold via enterprise field sales to pharma, medical device, and CRO buyers on a quote-based pricing model. Go-to-market combines direct enterprise sales, conference participation (SCOPE Summit, Heart Rhythm Society, ASCO, OCT series, DPHARM), and content marketing through downloadable capability materials. Leadership has been substantially refreshed in 2024-2025, including the appointment of Ciaran Cooper (formerly of Philips Pharma Solutions) as CEO and the addition of VPs of Client Services, Quality and Compliance, and a CFO, positioning the company for scaled operations following the IAG ecosystem expansion.

Short descriptiontext

HeartcoR Solutions is a US-based ECG core lab that delivers ECG recording, certified technician analysis, electrophysiologist overreading, and validated data sets to pharmaceutical, medical device, and CRO customers for global regulatory filings. It supports four ECG modalities with a multi-device portfolio across four continents.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSchaumburg, United States
HQ citystring
Schaumburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ECG core lab, cardiac safety monitoring, clinical trial services, centralized cardiac monitoring, cardiac imaging core lab
Industry4 codes
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Cardiac Safety Core Lab Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1ECG Core Lab Services
TypeProfessional Services
Description

HeartcoR provides expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to support pharmaceutical and medical device companies' global regulatory filings for clinical trials.

heartcorsolutions.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HeartcoR Solutions is a global ECG core lab that delivers expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery to support pharmaceutical, medical device, and biotech companies' global regulatory filings for clinical trials. The company sources and deploys advanced ECG recording devices (Event, MCT, Holter, 12-lead modes) at study sites, patient homes, and decentralized healthcare settings, and provides protocol-trained, sponsor-dedicated study teams for ongoing project continuity.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • More than 50,000 tracings completed annually
Product overview1 text field

HeartcoR Solutions operates as a specialized cardiac safety core lab offering a unified platform of ECG core lab services combined with a portfolio of remote patient monitoring devices. The core services encompass ECG recording, certified technician analysis, electrophysiologist overreading, and validated data delivery across four collection modes (Event, MCT, Holter, 12-lead). The device portfolio includes TempTraq (continuous temperature monitoring), PCA 500 (hospital-quality 12-lead ECG), Wellysis S-Patch EXL (wearable cardiac monitor), AliveCor (event recording), Vivalink Holter Patch (Holter/MCT recording), and Mortara 12-lead system—all integrated into clinical trial workflows to support pharmaceutical, medical device, and biotech companies' regulatory filings.

Product and service7 records
1ECG Core Lab Services
CategoryCardiac Safety Core Lab Services
Description

Expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery supporting global regulatory filings for pharmaceutical, medical device, and biotech companies' clinical trials. ECG data is collected across four modes: Event (60-second), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead ECG.

2TempTraq
CategoryRemote Patient Monitoring Device
Description

FDA-cleared, Class II medical device that delivers continuous, real-time body temperature monitoring for 72 hours via a one-time-use patch with Bluetooth connectivity, allowing patients to move freely during clinical trials.

3PCA 500
CategoryRemote Patient Monitoring Device
Description

Hospital-quality, 12-lead ECG device from QT Medical that can be easily applied by patients at home or at clinical trial sites. Includes a compact recorder, patented preconnected electrode strips, a mobile app, and a HIPAA-compliant cloud dashboard.

4Wellysis S-Patch EXL
CategoryRemote Patient Monitoring Device
Description

FDA-cleared wearable cardiac monitor designed for extended testing periods up to 14 days on a single battery charge. Lightweight (9g), waterproof patch with high arrhythmia detection rate, deployed for HeartcoR clinical trial partners.

5AliveCor
CategoryRemote Patient Monitoring Device
Description

ECG technology for 60-second event recordings, allowing clinical study participants to record ECG at any time within a study window. HeartcoR delivers a complete monitoring kit including a smartphone for easy data collection and transmission.

6Vivalink Holter Patch
CategoryRemote Patient Monitoring Device
Description

Wireless device for capture, transmission, and storage of Holter and Mobile Cardiac Telemetry (MCT) recordings. Features disposable adhesive, hydrogel for electrical connectivity, a reusable rechargeable design, and shower-resistant construction.

7Mortara AM 12-lead
CategoryRemote Patient Monitoring Device
Description

12-lead wireless recording device that pairs with a Microsoft Surface tablet. A preloaded application ensures easy activation, increased comfort for users, and simplified use for site personnel during clinical trial ECG collection.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCore/FlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-06
Description

Strategic partnership announced May 6, 2026 combining HeartcoR's ECG, cardiac monitoring, and endpoint adjudication services with IAG's multimodality imaging core lab expertise and DYNAMIKA technology platform. Creates an end-to-end workflow within a unified operational and data environment, enabling sponsors to reduce vendor fragmentation, access data faster, and strengthen safety narratives for regulatory submissions to global health authorities.

Strategic tierKeyTypeTechnology or Integration
Description

Partnership making the Wellysis S-Patch wearable ECG device available to HeartcoR's clinical trial partners. The FDA-cleared ExL model S-Patch is designed for extended testing periods up to 14 days, is lightweight (9g), waterproof, and minimizes noise while accurately collecting ECG waveforms.

Strategic tierSupportingTypeTechnology or Integration
Description

Added TempTraq device from Blue Spark Technologies, Inc. to HeartcoR's suite of remote patient monitoring devices. TempTraq is an FDA-cleared, Class II medical device for continuous, real-time body temperature monitoring with 72-hour operating life.

Strategic tierSupportingTypeTechnology or Integration
Description

Partnership for PCA 500 device from QT Medical - a hospital-quality, 12-lead ECG device that can be easily applied by patients at home or at clinical trial sites. Includes patented preconnected electrode strips and HIPAA-compliant cloud dashboard.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON is a global full-service CRO that offers cardiac safety and imaging core lab services alongside broader clinical operations. It competes with HeartcoR for sponsor cardiac safety work and is a common career path for HeartcoR's leadership alumni.

TypeDirect peer
Description

Philips' former BioTel Research business is a historical ECG and cardiac safety core lab serving pharma and device trials. It is a direct peer to HeartcoR, and several HeartcoR senior leaders (including the CEO and VP of Quality) previously held roles there.

TypeBroad incumbent
Description

IQVIA is the largest global CRO with broad cardiac safety and centralized diagnostic capabilities. As a broad incumbent, it competes with HeartcoR for large pharma cardiac safety contracts and can bundle ECG services into full-service offerings.

4Medifacts International
TypeDirect peer
Description

Medifacts is an ECG and cardiac safety core lab focused on centralized cardiac monitoring for clinical trials. It competes directly with HeartcoR on ECG core lab services for global pharma programs.

TypeEmerging player
Description

AliveCor is an FDA-cleared consumer and clinical ECG device maker whose KardiaMobile is also integrated into HeartcoR's device portfolio. It represents an emerging adjacent player that could evolve into a deeper core lab competitor or remain a partner.

TypeDirect peer
Description

BioTelemetry, now part of Philips, was one of the largest US cardiac monitoring companies and historically competed with HeartcoR's predecessor eCardio/Preventice. It remains a relevant peer in remote cardiac monitoring for clinical trials.

TypeBroad incumbent
Description

LabCorp's Covance segment provides central laboratory and cardiac safety services for clinical trials. It is a broad incumbent that overlaps with HeartcoR's ECG core lab offering for pharmaceutical sponsors.

TypeDirect peer
Description

Formed from the merger of Bioclinica and ERT, Clario is the largest dedicated cardiac safety and clinical endpoint core lab globally. It directly competes with HeartcoR on ECG core lab services for pharma and device trials and is the most relevant scale competitor.

TypeDirect peer
Description

Voiant (formerly WorldCare Clinical) is a clinical and imaging core lab that provides cardiac safety and imaging services. HeartcoR's VP of Client Services previously led operations there, indicating direct overlap and competitive positioning.

10Biomedical Systems
TypeDirect peer
Description

Biomedical Systems is a specialized cardiac safety and clinical trial core lab offering ECG, Holter, and imaging services to pharma and device sponsors. It is a direct specialist peer to HeartcoR in the ECG core lab niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HeartcoR Solutions

Cardiac Safety Core Lab Servicesheartcorsolutions.com

HeartcoR Solutions is a US-based ECG core lab that delivers ECG recording, certified technician analysis, electrophysiologist overreading, and validated data sets to pharmaceutical, medical device, and CRO customers for global regulatory filings. It supports four ECG modalities with a multi-device portfolio across four continents.

What HeartcoR Solutions does

HeartcoR Solutions is a US-based cardiac safety core lab founded in 2015 by Larry Lawson (formerly of eCardio/Preventice Solutions) and headquartered in Schaumburg, Illinois. The company delivers expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to pharmaceutical, medical device, and contract research organization (CRO) customers for global regulatory filings and post-market surveillance studies. It is positioned as the top choice for four of the largest global healthcare companies and also serves startups seeking initial market approval.

The core platform supports four ECG collection modes — Event (60-second recordings), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead — and is paired with a growing remote patient monitoring device portfolio including the Wellysis S-Patch EXL (under exclusive partnership), TempTraq, PCA 500, AliveCor, Vivalink Holter Patch, and Mortara 12-lead. HeartcoR sources, deploys, and integrates these devices at global study sites, patient homes, and decentralized healthcare settings across four continents, completing more than 50,000 tracings annually. A May 2026 strategic partnership with Image Analysis Group (IAG) extends the offering into integrated cardiac safety and multimodality imaging core lab services via IAG's DYNAMIKA platform, addressing sponsor demand for unified vendor relationships in regulatory submissions.

HeartcoR generates revenue through professional services tied to clinical trial cardiac safety monitoring (ECG core lab services), sold via enterprise field sales to pharma, medical device, and CRO buyers on a quote-based pricing model. Go-to-market combines direct enterprise sales, conference participation (SCOPE Summit, Heart Rhythm Society, ASCO, OCT series, DPHARM), and content marketing through downloadable capability materials. Leadership has been substantially refreshed in 2024-2025, including the appointment of Ciaran Cooper (formerly of Philips Pharma Solutions) as CEO and the addition of VPs of Client Services, Quality and Compliance, and a CFO, positioning the company for scaled operations following the IAG ecosystem expansion.

HeartcoR Solutions firmographics

Firmographics
Name
HeartcoR Solutions
Legal name
HeartcoR Solutions
Website
https://heartcorsolutions.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
HeartcoR Solutions is a US-based ECG core lab that delivers ECG recording, certified technician analysis, electrophysiologist overreading, and validated data sets to pharmaceutical, medical device, and CRO customers for global regulatory filings. It supports four ECG modalities with a multi-device portfolio across four continents.
Ownership category
akta.pro rank

HeartcoR Solutions industry classification

Industry
Product category
Cardiac Safety Core Lab Services
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • ECG core lab
  • Cardiac safety monitoring
  • Clinical trial services
  • Centralized cardiac monitoring
  • Cardiac imaging core lab

Where HeartcoR Solutions is headquartered

Location

Headquarters

HQ city
Schaumburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HeartcoR Solutions business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. ECG Core Lab Services: HeartcoR provides expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to support pharmaceutical and medical device companies' global regulatory filings for clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

HeartcoR Solutions product offering

Product offering

Core offering

HeartcoR Solutions is a global ECG core lab that delivers expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery to support pharmaceutical, medical device, and biotech companies' global regulatory filings for clinical trials. The company sources and deploys advanced ECG recording devices (Event, MCT, Holter, 12-lead modes) at study sites, patient homes, and decentralized healthcare settings, and provides protocol-trained, sponsor-dedicated study teams for ongoing project continuity.

Product overview

HeartcoR Solutions operates as a specialized cardiac safety core lab offering a unified platform of ECG core lab services combined with a portfolio of remote patient monitoring devices. The core services encompass ECG recording, certified technician analysis, electrophysiologist overreading, and validated data delivery across four collection modes (Event, MCT, Holter, 12-lead). The device portfolio includes TempTraq (continuous temperature monitoring), PCA 500 (hospital-quality 12-lead ECG), Wellysis S-Patch EXL (wearable cardiac monitor), AliveCor (event recording), Vivalink Holter Patch (Holter/MCT recording), and Mortara 12-lead system—all integrated into clinical trial workflows to support pharmaceutical, medical device, and biotech companies' regulatory filings.

Differentiator

Problem solved

Functional benefit

Products and services

  • ECG Core Lab Services Expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery supporting global regulatory filings for pharmaceutical, medical device, and biotech companies' clinical trials. ECG data is collected across four modes: Event (60-second), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead ECG.
  • TempTraq FDA-cleared, Class II medical device that delivers continuous, real-time body temperature monitoring for 72 hours via a one-time-use patch with Bluetooth connectivity, allowing patients to move freely during clinical trials.
  • PCA 500 Hospital-quality, 12-lead ECG device from QT Medical that can be easily applied by patients at home or at clinical trial sites. Includes a compact recorder, patented preconnected electrode strips, a mobile app, and a HIPAA-compliant cloud dashboard.
  • Wellysis S-Patch EXL FDA-cleared wearable cardiac monitor designed for extended testing periods up to 14 days on a single battery charge. Lightweight (9g), waterproof patch with high arrhythmia detection rate, deployed for HeartcoR clinical trial partners.
  • AliveCor ECG technology for 60-second event recordings, allowing clinical study participants to record ECG at any time within a study window. HeartcoR delivers a complete monitoring kit including a smartphone for easy data collection and transmission.
  • Vivalink Holter Patch Wireless device for capture, transmission, and storage of Holter and Mobile Cardiac Telemetry (MCT) recordings. Features disposable adhesive, hydrogel for electrical connectivity, a reusable rechargeable design, and shower-resistant construction.
  • Mortara AM 12-lead 12-lead wireless recording device that pairs with a Microsoft Surface tablet. A preloaded application ensures easy activation, increased comfort for users, and simplified use for site personnel during clinical trial ECG collection.

Quantifiable outcome

  • More than 50,000 tracings completed annually

Companies that use HeartcoR Solutions

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

HeartcoR Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

HeartcoR Solutions partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core/flagship, key and supporting.

  • Image Analysis Group (IAG)core/flagshipStrategic or Co-development Partner · 6 May 2026Strategic partnership announced May 6, 2026 combining HeartcoR's ECG, cardiac monitoring, and endpoint adjudication services with IAG's multimodality imaging core lab expertise and DYNAMIKA technology platform. Creates an end-to-end workflow within a unified operational and data environment, enabling sponsors to reduce vendor fragmentation, access data faster, and strengthen safety narratives for regulatory submissions to global health authorities.
  • WellysiskeyTechnology or IntegrationPartnership making the Wellysis S-Patch wearable ECG device available to HeartcoR's clinical trial partners. The FDA-cleared ExL model S-Patch is designed for extended testing periods up to 14 days, is lightweight (9g), waterproof, and minimizes noise while accurately collecting ECG waveforms.
  • Blue Spark Technologies, Inc.supportingTechnology or IntegrationAdded TempTraq device from Blue Spark Technologies, Inc. to HeartcoR's suite of remote patient monitoring devices. TempTraq is an FDA-cleared, Class II medical device for continuous, real-time body temperature monitoring with 72-hour operating life.
  • QT MedicalsupportingTechnology or IntegrationPartnership for PCA 500 device from QT Medical - a hospital-quality, 12-lead ECG device that can be easily applied by patients at home or at clinical trial sites. Includes patented preconnected electrode strips and HIPAA-compliant cloud dashboard.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

HeartcoR Solutions competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON is a global full-service CRO that offers cardiac safety and imaging core lab services alongside broader clinical operations. It competes with HeartcoR for sponsor cardiac safety work and is a common career path for HeartcoR's leadership alumni.
  • IQVIA: IQVIA is the largest global CRO with broad cardiac safety and centralized diagnostic capabilities. As a broad incumbent, it competes with HeartcoR for large pharma cardiac safety contracts and can bundle ECG services into full-service offerings.
  • Laboratory Corporation of America (Covance): LabCorp's Covance segment provides central laboratory and cardiac safety services for clinical trials. It is a broad incumbent that overlaps with HeartcoR's ECG core lab offering for pharmaceutical sponsors.

Direct peers

  • Philips BioTel Research (Philips Pharma Solutions): Philips' former BioTel Research business is a historical ECG and cardiac safety core lab serving pharma and device trials. It is a direct peer to HeartcoR, and several HeartcoR senior leaders (including the CEO and VP of Quality) previously held roles there.
  • Medifacts International: Medifacts is an ECG and cardiac safety core lab focused on centralized cardiac monitoring for clinical trials. It competes directly with HeartcoR on ECG core lab services for global pharma programs.
  • BioTelemetry (Philips): BioTelemetry, now part of Philips, was one of the largest US cardiac monitoring companies and historically competed with HeartcoR's predecessor eCardio/Preventice. It remains a relevant peer in remote cardiac monitoring for clinical trials.
  • Clario (Bioclinica + ERT): Formed from the merger of Bioclinica and ERT, Clario is the largest dedicated cardiac safety and clinical endpoint core lab globally. It directly competes with HeartcoR on ECG core lab services for pharma and device trials and is the most relevant scale competitor.
  • WorldCare Clinical (Voiant): Voiant (formerly WorldCare Clinical) is a clinical and imaging core lab that provides cardiac safety and imaging services. HeartcoR's VP of Client Services previously led operations there, indicating direct overlap and competitive positioning.
  • Biomedical Systems: Biomedical Systems is a specialized cardiac safety and clinical trial core lab offering ECG, Holter, and imaging services to pharma and device sponsors. It is a direct specialist peer to HeartcoR in the ECG core lab niche.

Emerging players

  • AliveCor: AliveCor is an FDA-cleared consumer and clinical ECG device maker whose KardiaMobile is also integrated into HeartcoR's device portfolio. It represents an emerging adjacent player that could evolve into a deeper core lab competitor or remain a partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

HeartcoR Solutions social profiles

Digital presence

HeartcoR Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HeartcoR Solutions leadership team

Management profile

Number of profiles

Profiles10 records

HeartcoR Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HeartcoR Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartcoR Solutions

What does HeartcoR Solutions do?

HeartcoR Solutions is a global ECG core lab that delivers expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery to support pharmaceutical, medical device, and biotech companies' global regulatory filings for clinical trials. The company sources and deploys advanced ECG recording devices (Event, MCT, Holter, 12-lead modes) at study sites, patient homes, and decentralized healthcare settings, and provides protocol-trained, sponsor-dedicated study teams for ongoing project continuity.

Is HeartcoR Solutions a public or private company?

HeartcoR Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was HeartcoR Solutions founded?

HeartcoR Solutions was founded in 2015. It employs 11 to 50 people.

Where is HeartcoR Solutions based?

HeartcoR Solutions is headquartered in Schaumburg, United States, in the North America region.

How does HeartcoR Solutions make money?

One revenue line is on record: ECG Core Lab Services.

Who are HeartcoR Solutions's main competitors?

Broad incumbents on record are ICON plc, IQVIA and Laboratory Corporation of America (Covance). Direct peers are Philips BioTel Research (Philips Pharma Solutions), Medifacts International, BioTelemetry (Philips), Clario (Bioclinica + ERT), WorldCare Clinical (Voiant) and Biomedical Systems. AliveCor is listed as an emerging player.

Does HeartcoR Solutions have an API?

No public API is recorded for HeartcoR Solutions.

What industry is HeartcoR Solutions in?

HeartcoR Solutions's product category is Cardiac Safety Core Lab Services. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG), with a secondary code of HLAKABAC, Electrophysiology (Heart Rhythm). Its NAICS code is 54169 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooImage Analysis Group (IAG) and HeartcoR Solutions Announce Strategic Partnership to Deliver Integrated Cardiac Safety and Imaging Core Lab Services for Clinical TrialsImage Analysis Group (IAG) and HeartcoR Solutions announced a strategic partnership on May 6, 2026, to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide. The partnership combines HeartcoR's core lab services (ECG, cardiac monitoring, endpoint adjudication) with IAG's multimodality imaging expertise and DYNAMIKA™ cloud platform to create an end-to-end workflow under unified governance. The collaboration aims to address fragmented data flows and operational burden by offering sponsors a single point of accountability and seamless data integration across cardiac and imaging modalities for regulatory submissions.DAICImage Analysis Group, HeartcoR Solutions Partner to Deliver Integrated Cardiac Safety, Imaging Core Lab Services for Clinical TrialsImage Analysis Group (IAG), a global imaging contract research organization headquartered in London, and HeartcoR Solutions announced a strategic partnership to deliver integrated cardiac safety monitoring and imaging core lab services to pharmaceutical and biotechnology sponsors. The partnership combines HeartcoR's core lab services (ECG, Cardiac Monitoring, Endpoint Adjudication) with IAG's multimodality imaging expertise and DYNAMIKA technology platform, creating an end-to-end workflow within a unified operational and data environment. The collaboration aims to reduce fragmented vendor relationships and operational burden while providing coordinated ECG, cardiac safety, and imaging data to support regulatory submissions to global health authorities.PR NewswireImage Analysis Group (IAG) and HeartcoR Solutions Announce Strategic Partnership to Deliver Integrated Cardiac Safety and Imaging Core Lab Services for Clinical TrialsImage Analysis Group (IAG), a London-headquartered global imaging CRO, and HeartcoR Solutions, a Schaumburg, IL-based specialized cardiac safety core lab, announced a strategic partnership to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide. The partnership combines HeartcoR's ECG, cardiac monitoring, and endpoint adjudication services with IAG's multimodality imaging core lab expertise and DYNAMIKA™ technology platform, creating an end-to-end workflow within a unified operational and data environment. This integration addresses a common industry challenge of fragmented vendor relationships by enabling sponsors to reduce the number of vendors, access data faster, and strengthen safety and efficacy narratives for regulatory submissions.EIN PresswireImage Analysis Group × HeartcoR Solutions – Press ReleaseImage Analysis Group and HeartcoR Solutions announced a strategic partnership to deliver integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors. The collaboration combines HeartcoR's cardiac safety core lab services with IAG's imaging core lab and DYNAMIKA platform, aiming to streamline operations and support regulatory submissions.PR NewswireHeartcoR Solutions Expands Suite of Remote Patient Monitoring Devices, Creating a One-Stop Shop for Clinical Trial PartnersHeartcoR Solutions added TempTraq and PCA 500 devices to its remote patient monitoring suite, creating a one-stop shop for clinical trial sponsors. The global RPM market is projected to grow at a CAGR of 19.8% from 2025 to 2033.YahooHeartcoR Solutions Expands Suite of Remote Patient Monitoring Devices, Creating a One-Stop Shop for Clinical Trial PartnersHeartcoR Solutions added TempTraq and PCA 500 devices to its remote patient monitoring suite, aiming to serve clinical trial sponsors as a one-stop shop. The global RPM market is projected to grow at a 19.8% CAGR from 2025 to 2033. The company expects these additions to improve subject access and reduce trial costs.PR NewswireHeartcoR Solutions Announces Exclusive Partnership with Wellysis to Make the Wellysis S-Patch Wearable ECG Device Available to HeartcoR's Clinical Trial PartnersHeartcoR Solutions announced an exclusive partnership with Wellysis to offer the Wellysis S-Patch wearable ECG device in global cardiac safety trials. The FDA-cleared device operates for up to 14 days on a single charge and is designed for remote monitoring. The collaboration aims to improve trial outcomes by providing easy-to-use remote monitoring.YahooHeartcoR Solutions Names Healthcare and Pharma Industry Veteran Ciaran Cooper as CEOHeartcoR Solutions named Ciaran Cooper CEO, bringing over 30 years of healthcare and pharmaceutical experience. He will guide expansion of remote patient monitoring and cardiac clinical safety trials into new markets. Founder Larry Lawson will continue leading the company.PRLogLeading ECG core lab company, HeartcoR Solutions, hires Michelle Moon as controllerHeartcoR Solutions hired Michelle Moon as controller to oversee accounting, reporting, analytics, and asset management. Moon brings over two decades of experience in sales, reporting, and data management, and will support the company's growth in core lab services.PrwebLarry Lawson Receives 2018 Horatio Alger AwardLarry Lawson, CEO of HeartcoR Solutions, was selected for the 2018 Horatio Alger Award, joining 11 other leaders. He overcame a serious bone deficiency and has donated $1 million to Lamar University. He will be inducted on April 5-7, 2018.